Denis DAVID
Full Professor in Pharmacology
Co-Head of MOODS team, U1018 Cesp-Inserm
@pharma_UPSaclay, @univparissaclay.bsky.social
Study psychiatric disorders
- Reposted by Denis DAVID[Not loaded yet]
- Reposted by Denis DAVIDAmazing presentations 👏🏽👏🏽👏🏽!! Thank you for sharing to all the courageous panelists ! Your resilience it is the prove that everything is possible! Impactful testimony 😍🙏🏽#Resilience #Perseverance #justbelieve 💪🏼👏🏽 #ACNP2026 @acnporg.bsky.social
- At the @acnporg.bsky.social #ACNP2026 Experience and Resilience Committee session describing how to build a Resilience Toolkit! In these times of trouble, we all need it! #Resilience
- The place to be tonight if you are attending #ACNP2026 @im74ve.bsky.social will present her latest data on repurposing #prucalopride to treat anxiety and depression @dpn-journal.bsky.social @npp-journal.bsky.social @pharmaupsaclay.bsky.social @gsheads.bsky.social
- If you’ve some free time stop by and say hi 👋🏽😉 Let’s talk about #5ht4R #Prucalopride #anxiolytic #newtreatmetns 🧠💊 Amazing collaboration wonderful people 😉@DrChristineAnnD @DenisJDavid @CorrubleE @MOODS_Inserm @UnivParisSaclay @Columbia @ACNPorg #ACNP2026 #ACNP2026 🇧🇸🤓😎
- Our latest papier is online: Leveraging Fiber Photometry to Decipher Neural Circuits Underlying Anxiety in Mice - Abdennebi - 2025 - Fundamental & Clinical Pharmacology - Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/...
- @im74ve.bsky.social and I are greatful for this recognition #neuroprismcolloque. A great pleasure to present our work on the 5-HT4R and discuss with colleagues and friends from @columbiapsych.bsky.social and other universities on #AI and psychiatry @pharmaupsaclay.bsky.social @gsheads.bsky.social
- Reposted by Denis DAVID[Not loaded yet]
- Venez échanger avec des sportifs de Hauts Niveau, des médecins et scientifiques autour du sport et de la santé mentale. #sport #santementale
- 3e édition du symposium sur la Santé Mentale. @pharmaupsaclay 🗓️ Le Sport, bien plus qu'une activité physique 📅 jeudi 27 mars 2025 📌 @Maison des Arts du Plessis-Robinson 🗒️ Inscription gratuite mais obligatoire ➡️ lnkd.in/ekVHqcXX En espérant vous voir nombreux #sante #santementale #sport
- Moods team, simply the best team
- Once again our annual scientific seminar overseas #Martinique 🇲🇶A total success sharing with colleagues and friends #scientificprojects #Futurecollaborations 🧑🏽🔬👨🔬👨🏼💻💊🧠 in a wonderful place 🏝️😎😉 looking forward for another exciting year 🍹😉 #Moods @univparissaclay.bsky.social @pharmaupsaclay.bsky.social
- Our latest paper entitled Synaptic Vesicle 2A (SV2A) Positron Emission Tomography (PET) Imaging as a Marker of Therapeutic Response in a Mouse Model of Depression is now available online. A great collaboration between #moodsteam and #shfj_cea pubs.acs.org/doi/full/10....
- Happy to talk with my colleagues Pr Delphine Joseph @delfjoseph.bsky.social on the interest of 5HT4 ligands to treat anxiety during the scientific day of @gsheads.bsky.social @im74ve.bsky.social #MOODS_Inserm @univparissaclay.bsky.social @pharmaupsaclay.bsky.social
- Lancement des 4eme journées scientifiques GS HeaDS en partenariat avec OI HEALTHI par Pr Delphine Joseph, Directrice GS et Marc Pallardy, Doyen UFR pharmacie @pharmaupsaclay.bsky.social @univparissaclay.bsky.social @delfjoseph.bsky.social @gsheads.bsky.social
- Reposted by Denis DAVID[Not loaded yet]
- Reposted by Denis DAVIDAn enriching environment and program 🤓🧠 #encephale2025 An amazing job from our scientific team #MOODS 💪🏼👏👏👏 @denisjdavid.bsky.social @olivierbonnot.bsky.social @univparissaclay.bsky.social @pharmaupsaclay.bsky.social @Congrès De L' Encéphale #portemaillotpalaisdescongres #Paris
- Great time at #encephale2025 talking about the pipelines to treat anxiety and depression with a special focus on serotonin type 4 receptor @gsheads.bsky.social @pharmaupsaclay.bsky.social
- The Moods preclinical teams @univparissaclay.bsky.social 🧬🧪
- Reposted by Denis DAVID[Not loaded yet]
